{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:07:57Z","timestamp":1771258077067,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,19]]},"DOI":"10.7759\/cureus.71876","type":"journal-article","created":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T19:52:46Z","timestamp":1729367566000},"source":"Crossref","is-referenced-by-count":1,"title":["Comparative Effectiveness of Novel Combination Therapies for Simultaneous Management of Hypertension and Hypercholesterolemia: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Apurva","family":"Popat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sweta","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200110000-00005","article-title":"High blood pressure and associated cardiovascular risk factors in France","volume":"19","author":"Asmar R","year":"2001","unstructured":"Asmar R, Vol S, Pannier B, Brisac AM, Tichet J, El Hasnaoui A. High blood pressure and associated cardiovascular risk factors in France. J Hypertens. 2001, 19:1727-32. 10.1097\/00004872-200110000-00005","journal-title":"J Hypertens"},{"key":"ref2","article-title":"Prevalence of comorbid hypertension and dyslipidemia and associated cardiovascular disease","volume":"10","author":"Johnson ML","year":"2004","unstructured":"Johnson ML, Pietz K, Battleman DS, Beyth RJ. Prevalence of comorbid hypertension and dyslipidemia and associated cardiovascular disease. Amer J Managed Care. 2004, 10:926-32.","journal-title":"Amer J Managed Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2001.2888","article-title":"Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women","volume":"23","author":"Thomas F","year":"2002","unstructured":"Thomas F, Bean K, Guize L, Quentzel S, Argyriadis P, Benetos A. Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (&lt;55 years) men and women. Eur Heart J. 2002, 23:528-35. 10.1053\/euhj.2001.2888","journal-title":"Eur Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000066","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APHA\/ash\/ASPC\/NMA\/PCNA guideline for the Prevention, Detection, Evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"71","author":"Whelton PK","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, et al.. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APHA\/ash\/ASPC\/NMA\/PCNA guideline for the Prevention, Detection, Evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018, 71:1269-324. 10.1161\/HYP.0000000000000066","journal-title":"Hypertension"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000131517.20177.5a","article-title":"Beneficial cardiovascular pleiotropic effects of statins","volume":"109","author":"Davignon J","year":"2004","unstructured":"Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation. 2004, 109:III39-43. 10.1161\/01.CIR.0000131517.20177.5a","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1002001","article-title":"Statins: another class of antihypertensive agents?","volume":"20","author":"Milionis HJ","year":"2006","unstructured":"Milionis HJ, Liberopoulos EN, Achimastos A, Elisaf MS, Mikhailidis DP. Statins: another class of antihypertensive agents?. J Hum Hypertens. 2006, 20:320-35. 10.1038\/sj.jhh.1002001","journal-title":"J Hum Hypertens"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-020-02965-2","article-title":"Blood pressure-lowering activity of statins: a systematic literature review and meta-analysis of placebo-randomized controlled trials","volume":"76","author":"Alghamdi J","year":"2020","unstructured":"Alghamdi J, Alqadi A, Alharf A, et al.. Blood pressure-lowering activity of statins: a systematic literature review and meta-analysis of placebo-randomized controlled trials. Eur J Clin Pharmacol. 2020, 76:1745-54. 10.1007\/s00228-020-02965-2","journal-title":"Eur J Clin Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12081","article-title":"Antihypertensive effects of statins: a meta-analysis of prospective controlled studies","volume":"15","author":"Briasoulis A","year":"2013","unstructured":"Briasoulis A, Agarwal V, Valachis A, Messerli FH. Antihypertensive effects of statins: a meta-analysis of prospective controlled studies. J Clin Hypertens (Greenwich). 2013, 15:310-20. 10.1111\/jch.12081","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref9","article-title":"Evaluation and Treatment of Cryptorchidism","author":"Penson DF","year":"2012","unstructured":"Penson DF, Krishnaswami S, Jules A, Seroogy JC, McPheeters ML. Evaluation and Treatment of Cryptorchidism. Agency for Healthcare Research and Quality (US), Rockville, MD; 2012."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2019.05.007","article-title":"Efficacy and Safety of a Fixed-Dose Combination of Candesartan and Rosuvastatin on Blood Pressure and Cholesterol in Patients With Hypertension and Hypercholesterolemia: A Multicenter, Randomized, Double-Blind, Parallel Phase III Clinical Study","volume":"41","author":"Cho KI","year":"2019","unstructured":"Cho KI, Kim BH, Park YH, et al.. Efficacy and Safety of a Fixed-Dose Combination of Candesartan and Rosuvastatin on Blood Pressure and Cholesterol in Patients With Hypertension and Hypercholesterolemia: A Multicenter, Randomized, Double-Blind, Parallel Phase III Clinical Study. Clin Ther. 2019, 41:1508-21. 10.1016\/j.clinthera.2019.05.007","journal-title":"Clin Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S280055","article-title":"Efficacy and safety of nebivolol and rosuvastatin combination treatment in patients with concomitant hypertension and hyperlipidemia","volume":"14","author":"Rhee MY","year":"2020","unstructured":"Rhee MY, Kim CH, Ahn Y, et al.. Efficacy and safety of nebivolol and rosuvastatin combination treatment in patients with concomitant hypertension and hyperlipidemia. Drug Des Devel Ther. 2020, 14:5005-17. 10.2147\/DDDT.S280055","journal-title":"Drug Des Devel Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2004.06.005","article-title":"Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance","volume":"17","author":"Fogari R","year":"2004","unstructured":"Fogari R, Derosa G, Lazzari P, Zoppi A, Fogari E, Rinaldi A, Mugellini A. Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance. Am J Hypertens. 2004, 17:823-7. 10.1016\/j.amjhyper.2004.06.005","journal-title":"Am J Hypertens"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-007-1008-7","article-title":"Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia","volume":"23","author":"Ge CJ","year":"2008","unstructured":"Ge CJ, Lu SZ, Chen YD, Wu XF, Hu SJ, Ji Y. Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia. Heart Vessels. 2008, 23:91-5. 10.1007\/s00380-007-1008-7","journal-title":"Heart Vessels"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2006.01.021","article-title":"The effects of simvastatin, losartan, and combined therapy on soluble CD40 ligand in hypercholesterolemic, hypertensive patients","volume":"190","author":"Han SH","year":"2007","unstructured":"Han SH, Koh KK, Quon MJ, Lee Y, Shin EK. The effects of simvastatin, losartan, and combined therapy on soluble CD40 ligand in hypercholesterolemic, hypertensive patients. Atherosclerosis. 2007, 190:205-11. 10.1016\/j.atherosclerosis.2006.01.021","journal-title":"Atherosclerosis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4070\/kcj.2015.45.3.225","article-title":"Additive beneficial effects of valsartan combined with rosuvastatin in the treatment of hypercholesterolemic hypertensive patients","volume":"45","author":"Jang JY","year":"2015","unstructured":"Jang JY, Lee SH, Kim BS, et al.. Additive beneficial effects of valsartan combined with rosuvastatin in the treatment of hypercholesterolemic hypertensive patients. Korean Circ J. 2015, 45:225-33. 10.4070\/kcj.2015.45.3.225","journal-title":"Korean Circ J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2017.10.013","article-title":"A randomized, multicenter, double-blind, placebo-controlled study to evaluate the efficacy and the tolerability of a triple combination of amlodipine\/losartan\/rosuvastatin in patients with comorbid essential hypertension and hyperlipidemia","volume":"39","author":"Lee HY","year":"2017","unstructured":"Lee HY, Kim SY, Choi KJ, et al.. A randomized, multicenter, double-blind, placebo-controlled study to evaluate the efficacy and the tolerability of a triple combination of amlodipine\/losartan\/rosuvastatin in patients with comorbid essential hypertension and hyperlipidemia. Clin Ther. 2017, 39:2366-79. 10.1016\/j.clinthera.2017.10.013","journal-title":"Clin Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2019.02.013","article-title":"Efficacy and tolerability of telmisartan\/amlodipine and rosuvastatin coadministration in hypertensive patients with hyperlipidemia: a Phase III, multicenter, randomized, double-blind study","volume":"41","author":"Kim TS","year":"2019","unstructured":"Kim TS, Rha SW, Kim SY, et al.. Efficacy and tolerability of telmisartan\/amlodipine and rosuvastatin coadministration in hypertensive patients with hyperlipidemia: a Phase III, multicenter, randomized, double-blind study. Clin Ther. 2019, 41:728-41. 10.1016\/j.clinthera.2019.02.013","journal-title":"Clin Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.652859","article-title":"Endothelial function and dysfunction: testing and clinical relevance","volume":"115","author":"Deanfield JE","year":"2007","unstructured":"Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007, 115:1285-95. 10.1161\/CIRCULATIONAHA.106.652859","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2021.106900","article-title":"Comparative efficacy of fixed-dose statin and antihypertensive agent combinations: a network meta-analysis of randomized controlled trials","volume":"141","author":"Bellos I","year":"2021","unstructured":"Bellos I, Pergialiotis V, Perrea DN. Comparative efficacy of fixed-dose statin and antihypertensive agent combinations: a network meta-analysis of randomized controlled trials. Vascul Pharmacol. 2021, 141:106900. 10.1016\/j.vph.2021.106900","journal-title":"Vascul Pharmacol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000000671","article-title":"Does co-administration of antihypertensive drugs and statins alter their efficacy and safety? A systematic review and meta-analysis of randomized controlled trials","volume":"73","author":"Kanukula R","year":"2019","unstructured":"Kanukula R, Esam H, Sundstr\u00f6m J, Rodgers A, Salam A. Does co-administration of antihypertensive drugs and statins alter their efficacy and safety? A systematic review and meta-analysis of randomized controlled trials. J Cardiovasc Pharmacol. 2019, 73:352-8. 10.1097\/FJC.0000000000000671","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2006.05636.x","article-title":"Efficacy and safety of coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia: results of the AVALON trial","volume":"8","author":"Messerli FH","year":"2006","unstructured":"Messerli FH, Bakris GL, Ferrera D, et al.. Efficacy and safety of coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia: results of the AVALON trial. J Clin Hypertens (Greenwich). 2006, 8:571-81; quiz 582-3. 10.1111\/j.1524-6175.2006.05636.x","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.06.008","article-title":"Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions","volume":"96","author":"Mason RP","year":"2005","unstructured":"Mason RP, Walter MF, Day CA, Jacob RF. Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions. Am J Cardiol. 2005, 96:11-23F. 10.1016\/j.amjcard.2005.06.008","journal-title":"Am J Cardiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12020","article-title":"Effect of simvastatin on the antihypertensive activity of losartan in hypertensive hypercholesterolemic animals and patients: role of nitric oxide, oxidative stress, and high-sensitivity C-reactive protein","volume":"28","author":"Abdel-Zaher AO","year":"2014","unstructured":"Abdel-Zaher AO, Elkoussi AE, Abudahab LH, Elbakry MH, Elsayed EA. Effect of simvastatin on the antihypertensive activity of losartan in hypertensive hypercholesterolemic animals and patients: role of nitric oxide, oxidative stress, and high-sensitivity C-reactive protein. Fundam Clin Pharmacol. 2014, 28:237-48. 10.1111\/fcp.12020","journal-title":"Fundam Clin Pharmacol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-007-9491-1","article-title":"Synergistic effect of amlodipine and atorvastatin in reversing LDL-induced endothelial dysfunction","volume":"25","author":"Mason RP","year":"2008","unstructured":"Mason RP, Kubant R, Heeba G, et al.. Synergistic effect of amlodipine and atorvastatin in reversing LDL-induced endothelial dysfunction. Pharm Res. 2008, 25:1798-806. 10.1007\/s11095-007-9491-1","journal-title":"Pharm Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-006-0176-1","article-title":"Effects of amlodipine-atorvastatin combination on inflammation markers and insulin sensitivity in normocholesterolemic obese hypertensive patients","volume":"62","author":"Fogari R","year":"2006","unstructured":"Fogari R, Preti P, Zoppi A, et al.. Effects of amlodipine-atorvastatin combination on inflammation markers and insulin sensitivity in normocholesterolemic obese hypertensive patients. Eur J Clin Pharmacol. 2006, 62:817-22. 10.1007\/s00228-006-0176-1","journal-title":"Eur J Clin Pharmacol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200004000-00006","article-title":"Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia","volume":"35","author":"Borghi C","year":"2000","unstructured":"Borghi C, Prandin MG, Costa FV, Bacchelli S, Degli Esposti D, Ambrosioni E. Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia. J Cardiovasc Pharmacol. 2000, 35:549-55. 10.1097\/00005344-200004000-00006","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1081\/JDI-56610","article-title":"Statin therapy helps to control blood pressure levels in hypertensive dyslipidemic patients","volume":"27","author":"Kanbay M","year":"2005","unstructured":"Kanbay M, Yildirir A, Bozbas H, et al.. Statin therapy helps to control blood pressure levels in hypertensive dyslipidemic patients. Ren Fail. 2005, 27:297-303. 10.1081\/JDI-56610","journal-title":"Ren Fail"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(99)80621-3","article-title":"Effects of pravastatin on cardiovascular reactivity to norepinephrine and angiotensin II in patients with hypercholesterolemia and systemic hypertension","volume":"75","author":"Straznicky NE","year":"1995","unstructured":"Straznicky NE, Howes LG, Lam W, Louis WJ. Effects of pravastatin on cardiovascular reactivity to norepinephrine and angiotensin II in patients with hypercholesterolemia and systemic hypertension. Am J Cardiol. 1995, 75:582-6. 10.1016\/s0002-9149(99)80621-3","journal-title":"Am J Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2013.35","article-title":"Blood pressure-lowering effect of simvastatin: a placebo-controlled randomized clinical trial with 24-h ambulatory blood pressure monitoring","volume":"28","author":"Correa V Jr","year":"2014","unstructured":"Correa V Jr, Fuchs FD, Moreira LB, et al.. Blood pressure-lowering effect of simvastatin: a placebo-controlled randomized clinical trial with 24-h ambulatory blood pressure monitoring. J Hum Hypertens. 2014, 28:62-7. 10.1038\/jhh.2013.35","journal-title":"J Hum Hypertens"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000259737.43916.42","article-title":"Do statins reduce blood pressure?: a meta-analysis of randomized, controlled trials","volume":"49","author":"Strazzullo P","year":"2007","unstructured":"Strazzullo P, Kerry SM, Barbato A, Versiero M, D'Elia L, Cappuccio FP. Do statins reduce blood pressure?: a meta-analysis of randomized, controlled trials. Hypertension. 2007, 49:792-8. 10.1161\/01.HYP.0000259737.43916.42","journal-title":"Hypertension"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-01002-8","article-title":"Treatment of hypertensive and hypercholesterolaemic patients with the Triple fixed combination of atorvastatin, perindopril and amlodipine: the results of the coral study","volume":"36","author":"Simon A","year":"2019","unstructured":"Simon A, D\u00e9zsi CA. Treatment of hypertensive and hypercholesterolaemic patients with the Triple fixed combination of atorvastatin, perindopril and amlodipine: the results of the coral study. Adv Ther. 2019, 36:2010-20. 10.1007\/s12325-019-01002-8","journal-title":"Adv Ther"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.277064","article-title":"Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial","volume":"310","author":"Thom S","year":"2013","unstructured":"Thom S, Poulter N, Field J, et al.. Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial. JAMA. 2013, 310:918-29. 10.1001\/jama.2013.277064","journal-title":"JAMA"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2016.09.005","article-title":"Blood pressure and cholesterol-lowering efficacy of a fixed-dose combination with irbesartan and atorvastatin in patients with hypertension and hypercholesterolemia: a randomized, double-blind, factorial, multicenter phase III study","volume":"38","author":"Kim S-H","year":"2016","unstructured":"Kim S-H, Jo S-H, Lee S-C, et al.. Blood pressure and cholesterol-lowering efficacy of a fixed-dose combination with irbesartan and atorvastatin in patients with hypertension and hypercholesterolemia: a randomized, double-blind, factorial, multicenter phase III study. Clin Ther. 2016, 38:2171-84. 10.1016\/j.clinthera.2016.09.005","journal-title":"Clin Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/301379-comparative-effectiveness-of-novel-combination-therapies-for-simultaneous-management-of-hypertension-and-hypercholesterolemia-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T19:52:48Z","timestamp":1729367568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/301379-comparative-effectiveness-of-novel-combination-therapies-for-simultaneous-management-of-hypertension-and-hypercholesterolemia-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,19]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.71876","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,19]]}}}